Hui Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Venues

mBio

Signal transduction and targeted therapy

Journal of virology

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Mo Zhou, Tao Yang, Ming Yuan, Xinyu Li, Jieyi Deng, Shiyu Wu, Zhihan Zhong, Yingtong Lin, Wanying Zhang, Baijin Xia, Yating Wu, Lilin Wang, Tao Chen, Ruxin Liu, Ting Pan, Xiancai Ma, Linghua Li, Bingfeng Liu, Hui Zhang
ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of virology (2024)
Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, Shiqi Xiao, Meilin Hu, Taizhen Liang, Tao Chen, Xuepeng Wei, Zhenglai Zhang, Sen Liu, Han Liu, Yiqiang Zhu, Guangyan Liu, Tianyong Tu, Peiwen Li, Hui Zhang, Ting Pan, Xiancai Ma
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. mBio 15 (8) (2024)
Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, Shiqi Xiao, Meilin Hu, Taizhen Liang, Tao Chen, Xuepeng Wei, Zhenglai Zhang, Sen Liu, Han Liu, Yiqiang Zhu, Guangyan Liu, Tianyong Tu, Peiwen Li, Hui Zhang, Ting Pan, Xiancai Ma
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. mBio 15 (8) (2024)
Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, Shiqi Xiao, Meilin Hu, Taizhen Liang, Tao Chen, Xuepeng Wei, Zhenglai Zhang, Sen Liu, Han Liu, Yiqiang Zhu, Guangyan Liu, Tianyong Tu, Peiwen Li, Hui Zhang, Ting Pan, Xiancai Ma
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. mBio 15 (8) (2024)
Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio 15 (3) (2024)
Mo Zhou, Tao Yang, Ming Yuan, Xinyu Li, Jieyi Deng, Shiyu Wu, Zhihan Zhong, Yingtong Lin, Wanying Zhang, Baijin Xia, Yating Wu, Lilin Wang, Tao Chen, Ruxin Liu, Ting Pan, Xiancai Ma, Linghua Li, Bingfeng Liu, Hui Zhang
ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of virology 98 (8) (2024)
Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio 15 (3) (2024)
Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Airu Zhu, Yaochang Yuan, Yingtong Lin, Achun Chen, Jinzhu Feng, Xiumei Wang, Shijian Wu, Yingying Liu, Jie Liu, Yalin Wang, Rong Li, Chaofeng Liang, Quyu Yuan, Yu Liang, Qiannan Fang, Zhihui Xi, Wenjie Li, Liting Liang, Zhenglai Zhang, Hui Tang, Yi Peng, Changwen Ke, Xiancai Ma, Wei-Bin Cai, Ting Pan, Bingfeng Liu, Kai Deng, Jun Chen, Jin-Cun Zhao, Xuepeng Wei, Ran Chen, Yiwen Zhang, Hui Zhang
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nature immunology 25 (4) (2024)
Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Airu Zhu, Yaochang Yuan, Yingtong Lin, Achun Chen, Jinzhu Feng, Xiumei Wang, Shijian Wu, Yingying Liu, Jie Liu, Yalin Wang, Rong Li, Chaofeng Liang, Quyu Yuan, Yu Liang, Qiannan Fang, Zhihui Xi, Wenjie Li, Liting Liang, Zhenglai Zhang, Hui Tang, Yi Peng, Changwen Ke, Xiancai Ma, Wei-Bin Cai, Ting Pan, Bingfeng Liu, Kai Deng, Jun Chen, Jin-Cun Zhao, Xuepeng Wei, Ran Chen, Yiwen Zhang, Hui Zhang
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nature immunology (2024)
Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio 15 (3) (2024)
Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, Shiqi Xiao, Meilin Hu, Taizhen Liang, Tao Chen, Xuepeng Wei, Zhenglai Zhang, Sen Liu, Han Liu, Yiqiang Zhu, Guangyan Liu, Tianyong Tu, Peiwen Li, Hui Zhang, Ting Pan, Xiancai Ma
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. mBio (2024)
Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio (2024)
Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Airu Zhu, Yaochang Yuan, Yingtong Lin, Achun Chen, Jinzhu Feng, Xiumei Wang, Shijian Wu, Yingying Liu, Jie Liu, Yalin Wang, Rong Li, Chaofeng Liang, Quyu Yuan, Yu Liang, Qiannan Fang, Zhihui Xi, Wenjie Li, Liting Liang, Zhenglai Zhang, Hui Tang, Yi Peng, Changwen Ke, Xiancai Ma, Wei-Bin Cai, Ting Pan, Bingfeng Liu, Kai Deng, Jun Chen, Jin-Cun Zhao, Xuepeng Wei, Ran Chen, Yiwen Zhang, Hui Zhang
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nature immunology 25 (4) (2024)
Fei Yu, Yingshi Chen, Mo Zhou, Lingling Liu, Bingfeng Liu, Jun Liu, Ting Pan, Yuewen Luo, Xu Zhang, Hailan Ou, Wenjing Huang, Xi Lv, Zhihui Xi, Ruozhi Xiao, Wenyu Li, Lixue Cao, Xiancai Ma, Jingwen Zhang, Lijuan Lu, Hui Zhang
Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway. Cell death discovery 10 (1) (2024)
Fei Yu, Yingshi Chen, Mo Zhou, Lingling Liu, Bingfeng Liu, Jun Liu, Ting Pan, Yuewen Luo, Xu Zhang, Hailan Ou, Wenjing Huang, Xi Lv, Zhihui Xi, Ruozhi Xiao, Wenyu Li, Lixue Cao, Xiancai Ma, Jingwen Zhang, Lijuan Lu, Hui Zhang
Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway. Cell death discovery 10 (1) (2024)
Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, Shiqi Xiao, Meilin Hu, Taizhen Liang, Tao Chen, Xuepeng Wei, Zhenglai Zhang, Sen Liu, Han Liu, Yiqiang Zhu, Guangyan Liu, Tianyong Tu, Peiwen Li, Hui Zhang, Ting Pan, Xiancai Ma
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. mBio (2024)
Mo Zhou, Tao Yang, Ming Yuan, Xinyu Li, Jieyi Deng, Shiyu Wu, Zhihan Zhong, Yingtong Lin, Wanying Zhang, Baijin Xia, Yating Wu, Lilin Wang, Tao Chen, Ruxin Liu, Ting Pan, Xiancai Ma, Linghua Li, Bingfeng Liu, Hui Zhang
ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of virology 98 (8) (2024)
Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio (2024)
Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Airu Zhu, Yaochang Yuan, Yingtong Lin, Achun Chen, Jinzhu Feng, Xiumei Wang, Shijian Wu, Yingying Liu, Jie Liu, Yalin Wang, Rong Li, Chaofeng Liang, Quyu Yuan, Yu Liang, Qiannan Fang, Zhihui Xi, Wenjie Li, Liting Liang, Zhenglai Zhang, Hui Tang, Yi Peng, Changwen Ke, Xiancai Ma, Wei-Bin Cai, Ting Pan, Bingfeng Liu, Kai Deng, Jun Chen, Jin-Cun Zhao, Xuepeng Wei, Ran Chen, Yiwen Zhang, Hui Zhang
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nature immunology 25 (4) (2024)
Mo Zhou, Tao Yang, Ming Yuan, Xinyu Li, Jieyi Deng, Shiyu Wu, Zhihan Zhong, Yingtong Lin, Wanying Zhang, Baijin Xia, Yating Wu, Lilin Wang, Tao Chen, Ruxin Liu, Ting Pan, Xiancai Ma, Linghua Li, Bingfeng Liu, Hui Zhang
ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of virology 98 (8) (2024)
Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jin-Cun Zhao, Lin Feng
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19. Emerging microbes & infections 12 (1) (2023)
Yiwen Zhang, Rong Li, Yuzhuang Li, Hong Yang, Liqiong Zhou, Jing Yuan, Ting Pan, Bingfeng Liu, Hui Zhang, Yaqing He
Antibody response and cross-neutralization after Omicron BA.2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Bao Zhang, Peng He, John E G Lawrence, Shuaiyu Wang, Elizabeth Tuck, Brian A Williams, Kenny Roberts, Vitalii Kleshchevnikov, Lira Mamanova, Liam Bolt, Krzysztof Polański, Tong Li, Rasa Elmentaite, Eirini S Fasouli, Martin Prete, Xiaoling He, Nadav Yayon, Yixi Fu, Hao Yang, Chen Liang, Hui Zhang, Raphael Blain, Alain Chédotal, David R FitzPatrick, Helen Firth, Andrew Dean, Omer Ali Bayraktar, John C Marioni, Roger A Barker, Mekayla A Storer, Barbara J Wold, Hongbo Zhang, Sarah A Teichmann
A human embryonic limb cell atlas resolved in space and time. Nature (2023)
Yiwen Zhang, Rong Li, Yuzhuang Li, Hong Yang, Liqiong Zhou, Jing Yuan, Ting Pan, Bingfeng Liu, Hui Zhang, Yaqing He
Antibody response and cross-neutralization after Omicron BA.2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Yiwen Zhang, Rong Li, Yuzhuang Li, Hong Yang, Liqiong Zhou, Jing Yuan, Ting Pan, Bingfeng Liu, Hui Zhang, Yaqing He
Antibody response and cross-neutralization after Omicron BA.2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Yiwen Zhang, Rong Li, Yuzhuang Li, Hong Yang, Liqiong Zhou, Jing Yuan, Ting Pan, Bingfeng Liu, Hui Zhang, Yaqing He
Antibody response and cross-neutralization after Omicron BA.2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jin-Cun Zhao, Lin Feng
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19. Emerging microbes & infections 12 (1) (2023)
Xiantao Zhang, Shijian Wu, Jie Liu, Ran Chen, Yongli Zhang, Yingtong Lin, Zhihui Xi, Jieyi Deng, Zeyu Pu, Chaofeng Liang, Jinzhu Feng, Rong Li, Keming Lin, Mo Zhou, Yingying Liu, Xu Zhang, Bingfeng Liu, Yiwen Zhang, Xin He, Hui Zhang
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Liyang Wu, Ting Pan, Mo Zhou, Tao Chen, Shiyu Wu, Xi Lv, Jun Liu, Fei Yu, Yuanjun Guan, Bingfeng Liu, Wanying Zhang, Xiaohui Deng, Qianyu Chen, Anqi Liang, Yingtong Lin, Lilin Wang, Xiaoping Tang, Weiping Cai, Linghua Li, Xin He, Hui Zhang, Xiancai Ma
CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2. EMBO reports 23 (7) (2022)
Xiaofei Wang, Ao Hu, Xiangyu Chen, Yixin Zhang, Fei Yu, Shuai Yue, Arong Li, Junsong Zhang, Zhiwei Pan, Yang Yang, Yao Lin, Leiqiong Gao, Jing Zhou, Jing Zhao, Fang Li, Yaling Shi, Feng Huang, Xiaofan Yang, Yi Peng, Luoyang Tu, Huan Zhang, Huanying Zheng, Jun He, Hui Zhang, Lifan Xu, Qizhao Huang, Yongqun Zhu, Kai Deng, Lilin Ye
A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD. Signal transduction and targeted therapy 7 (1) (2022)
Ran Chen, Xiantao Zhang, Yaochang Yuan, Xiaohui Deng, Bolin Wu, Zhihui Xi, Guanwen Wang, Yingtong Lin, Rong Li, Xuemei Wang, Fan Zou, Liting Liang, Haiping Yan, Chaofeng Liang, Yuzhuang Li, Shijian Wu, Jieyi Deng, Mo Zhou, Xu Zhang, Congrong Li, Xiuqing Bu, Yi Peng, Changwen Ke, Kai Deng, Xin He, Yiwen Zhang, Zhenhai Zhang, Ting Pan, Hui Zhang
Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (11) (2022)
Wanying Zhang, Mo Zhou, Cancan Chen, Shiyu Wu, Lilin Wang, Baijin Xia, Jun Liu, Xiancai Ma, Ting Pan, Hui Zhang, Linghua Li, Bingfeng Liu
Identification of CD98 as a Novel Biomarker for HIV-1 Permissiveness and Latent Infection. mBio (2022)
Yang Liu, Yuewen Luo, Shumei Yan, Yi-Fan Lian, Shiyu Wu, Miao Xu, Lin Feng, Xu Zhang, Rong Li, Xiantao Zhang, Qi-Sheng Feng, Yi-Xin Zeng, Hui Zhang
CRL2 KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression. Oncogene 41 (22) (2022)
Xiantao Zhang, Hui Zhang, Xin He
SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine. Signal transduction and targeted therapy 7 (1) (2022)
Yuewen Luo, Xiantao Zhang, Ran Chen, Rong Li, Yang Liu, Junsong Zhang, Qin Liu, Meijun Si, Jun Liu, Bolin Wu, Xuemei Wang, Shijian Wu, Yiwen Zhang, Xu Zhang, De-Ying Guo, Xin He, Ting Pan, Hui Zhang
USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID. Signal transduction and targeted therapy 7 (1) (2022)
Ting Pan, Zhongwei Hu, Fengyu Hu, Yiwen Zhang, Bingfeng Liu, Changwen Ke, Qiumin She, Xin He, Xiaoping Tang, Hui Zhang
Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains. Cellular & molecular immunology 18 (11) (2021)
Ting Pan, Ran Chen, Xin He, Yaochang Yuan, Xiaohui Deng, Rong Li, Haiping Yan, Shumei Yan, Jun Liu, Yiwen Zhang, Xiantao Zhang, Fei Yu, Mo Zhou, Changwen Ke, Xiancai Ma, Hui Zhang
Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route. Signal transduction and targeted therapy 6 (1) (2021)
Xiancai Ma, Tao Chen, Zhilin Peng, Ziwen Wang, Jun Liu, Tao Yang, Liyang Wu, Guangyan Liu, Mo Zhou, Muye Tong, Yuanjun Guan, Xu Zhang, Yingtong Lin, Xiaoping Tang, Linghua Li, Zhonghui Tang, Ting Pan, Hui Zhang
Histone chaperone CAF-1 promotes HIV-1 latency by leading the formation of phase-separated suppressive nuclear bodies. The EMBO journal 40 (10) (2021)
Yuewen Luo, Fei Yu, Mo Zhou, Yang Liu, Baijin Xia, Xiantao Zhang, Jun Liu, Junsong Zhang, Yingying Du, Rong Li, Liyang Wu, Xu Zhang, Ting Pan, De-Ying Guo, Tao Peng, Hui Zhang
Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors. mBio 12 (1) (2021)
Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He, Hui Zhang
Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques. Cellular & molecular immunology 18 (4) (2021)
Xiantao Zhang, Yaochang Yuan, Bolin Wu, Xuemei Wang, Yingtong Lin, Yuewen Luo, Rong Li, Tao Chen, Jieyi Deng, Xu Zhang, Fan Zou, Xin He, Hui Zhang
Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles. Cellular & molecular immunology 18 (8) (2021)
Yiwen Zhang, Yingshi Chen, Yuzhuang Li, Feng Huang, Baohong Luo, Yaochang Yuan, Baijin Xia, Xiancai Ma, Tao Yang, Fei Yu, Jun Liu, Bingfeng Liu, Zheng Song, Jingliang Chen, Shumei Yan, Liyang Wu, Ting Pan, Xu Zhang, Rong Li, Wenjing Huang, Xin He, Fei Xiao, Junsong Zhang, Hui Zhang
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι. Proceedings of the National Academy of Sciences of the United States of America 118 (23) (2021)
Yiwen Zhang, Hongrong Hu, Weiwei Liu, Shu-Mei Yan, Yuzhuang Li, Likai Tan, Yingshi Chen, Jun Liu, Zhilin Peng, Yaochang Yuan, Wenjing Huang, Fei Yu, Xin He, Bo Li, Hui Zhang
Amino acids and RagD potentiate mTORC1 activation in CD8+ T cells to confer antitumor immunity. Journal for immunotherapy of cancer 9 (4) (2021)
Xiantao Zhang, Shijian Wu, Bolin Wu, Qirui Yang, Achun Chen, Yuzhuang Li, Yiwen Zhang, Ting Pan, Hui Zhang, Xin He
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal transduction and targeted therapy 6 (1) (2021)
Junsong Zhang, Jun Liu, Yaochang Yuan, Feng Huang, Rong Ma, Baohong Luo, Zhihui Xi, Ting Pan, Bingfeng Liu, Yiwen Zhang, Xu Zhang, Yuewen Luo, Jin Wang, Meng Zhao, Gen Lu, Kai Deng, Hui Zhang
Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis. PLoS pathogens 16 (2) (2020)
Xiancai Ma, Tao Yang, Yuewen Luo, Liyang Wu, Yawen Jiang, Zheng Song, Ting Pan, Bingfeng Liu, Guangyan Liu, Jun Liu, Fei Yu, Zhangping He, Wanying Zhang, Jinyu Yang, Liting Liang, Yuanjun Guan, Xu Zhang, Linghua Li, Weiping Cai, Xiaoping Tang, Song Gao, Kai Deng, Hui Zhang
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb. eLife 8 (2019)
Ting Pan, Zheng Song, Liyang Wu, Guangyan Liu, Xiancai Ma, Zhilin Peng, Mo Zhou, Liting Liang, Bingfeng Liu, Jun Liu, Junsong Zhang, Xuanhong Zhang, Ryan Huang, Jiacong Zhao, Yonghong Li, Xuemei Ling, Yuewen Luo, Xiaoping Tang, Weiping Cai, Kai Deng, Linghua Li, Hui Zhang
USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication. eLife 8 (2019)
Feng Huang, Jingliang Chen, Junsong Zhang, Likai Tan, Gui Lu, Yongjie Luo, Ting Pan, Juanran Liang, Qianwen Li, Baohong Luo, Hui Zhang, Gen Lu
Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein. Journal of cellular and molecular medicine 22 (3) (2017)

Hui Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui Zhang